Category archive

Arrhythmias

Traveling with a Pacemaker

The Advanced Imaging Technology full body scanner will not harm your pacemaker system or change the settings. from Boston Scientific Traveling with a Pacemaker It’s important to know that you can travel safely with a pacemaker device as long as you know how to prepare and talk to your doctor about any special precautions to take. Learn more about going through airport security, finding a doctor while traveling and other tips for having a successful trip with a pacemaker. Important…

Keep Reading

FDA Approves First Wire-Free Pacemaker

From US News and World Report –April 7, 2107 –Robert Preidt The first leadless, wire-free heart pacemaker has been approved by the U.S. Food and Drug Administration. Medtronic’s Micra Transcatheter Pacing System works like other pacemakers to regulate heart rate in people with heart rhythm disorders, but does not use wired leads to make the electrical connection between the device and the heart. One expert believes the device’s approval is a big win for heart patients. “The leadless pacemaker is…

Keep Reading

Avoiding Atrial Fibrillation

the puzzle of atrial fibrillation

  We have good evidence from multiple studies showing that people who are overweight have a higher risk of afib than people who are at a healthy weight. Harvard Health Letter  –February 14, 2017 Maintaining a healthy weight and other lifestyle habits can help prevent this common heart rhythm disorder. During a bout of atrial fibrillation, your heart may beat so rapidly, it may feel as though it’s going to explode out of your chest. Commonly known as afib, this…

Keep Reading

Comparing Blood-Thinners for Atrial Fibrillation

Apixaban [Eliquis] scores highest of all the NOACs, “on the balance of efficacy, safety and cost.” Pharmacy News December 5, 2017 Which NOAC scores highest for atrial fibrillation? New ranking may help guide decision-making Apixaban is the most efficient non-vitamin K oral anticoagulant (NOAC) for treating atrial fibrillation, according to the results of a meta-analysis including 95,000 patients from 23 randomised controlled trial. There’s already a large body of evidence that NOACs are at least as effective as warfarin and…

Keep Reading

FDA: Atrial Fibrillation and New Oral Anticoagulant Drugs

From the US Food and Drug Administration October 2016 Ellis F. Unger, M.D. More than 3 million Americans have atrial fibrillation, a problem with the electrical system of the heart that causes an irregular heart rhythm. Atrial fibrillation can produce palpitations, shortness of breath, lightheadedness, weakness, and chest pain, or may occur without symptoms. The main concern, however, is that atrial fibrillation can lead to the formation of blood clots in the heart, which can travel to the brain and…

Keep Reading

Go to Top